MiR-19b-3p Serves as a Potential Diagnostic Biomarker for Parkinson's Disease

被引:0
作者
Wu, Jing [1 ]
Cao, Wei [1 ]
Wei, Wei [1 ]
Zhang, Dandan [1 ]
Li, Xuezhong [1 ]
Wang, Yi [2 ,3 ]
Chen, Xiaopeng [1 ]
机构
[1] Jiangsu Univ, Affiliated Peoples Hosp, Dept Neurol, 8 Dianli Rd, Zhenjiang 212002, Jiangsu, Peoples R China
[2] Peoples Hosp Jurong City, Dept Neurol, Jurong, Jiangsu, Peoples R China
[3] Jiangsu Univ, Jurong Hosp, Dept Neurol, Jurong, Jiangsu, Peoples R China
关键词
MiR-19b-3p; Parkinson's disease; inflammatory factors; biomarker; SERUM-LEVELS; EXOSOME; CANCER;
D O I
10.7754/Clin.Lab.2024.240639
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Hundreds of miRNAs have been reported to be dysregulated in Parkinson's disease (PD), providing valuable assistance in improving its diagnosis. The purpose of this study was to analyze the expression and diagnostic value of miR-19b-3p in PD patients, as well as its relationship with inflammatory factors. Methods: We recruited 50 PD patients and 50 healthy age- and gender-matched controls and collected demographic data and biochemical parameters from both groups. RT-qPCR was used to detect miR-19b-3p levels in serum. ELISA was used to detect serum levels of TNF-alpha and IL-1 beta. Receiver operating characteristic (ROC) curves were constructed to evaluate the diagnostic value of miR-19b-3p in PD patients. Results: Serum miR-19b-3p expression was downregulated in PD patients compared with healthy controls. A negative correlation was found between miR-19b-3p levels and the MDS-UPDRS score in PD patients (r =-0.686, p < 0.01). In ROC curve analysis, the area under the curve of miR-19b-3p for prediction of PD was 0.779. In PD patients, serum miR-19b-3p levels were negatively correlated with serum IL-1 beta (r =-0.556, p < 0.01) and TNF-alpha levels (r =-0.592, p < 0.01).<br /> Conclusions: Serum miR-19b-3p might serve as a diagnostic and predictive biomarker for PD. The association detected between miR-19b-3p and two common markers of inflammation (IL-1 beta and TNF-alpha) may suggest a role for miR-19b-3p in PD-associated neuroinflammation.
引用
收藏
页码:2283 / 2289
页数:7
相关论文
共 31 条
  • [1] Postuma RB, Poewe W, Litvan I, Et al., Validation of the MDS clinical diagnostic criteria for Parkinson's disease, Mov Disord, 33, 10, pp. 1601-1608, (2018)
  • [2] Dorsey ER, Bloem BR., The Parkinson Pandemic-A Call to Action, JAMA Neurol, 75, 1, pp. 9-10, (2018)
  • [3] Dorsey ER, Constantinescu R, Thompson JP, Et al., Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030, Neurology, 68, 5, pp. 384-386, (2007)
  • [4] Yasuhara T., Neurobiology Research in Parkinson's Disease, Int J Mol Sci, 21, 3, (2020)
  • [5] Athauda D, Foltynie T., The ongoing pursuit of neuroprotective therapies in Parkinson disease, Nat Rev Neurol, 11, 1, pp. 25-40, (2015)
  • [6] Fayyad M, Salim S, Majbour N, Et al., Parkinson's disease biomarkers based on alpha-synuclein, J Neurochem, 150, 5, pp. 626-636, (2019)
  • [7] Acharya S, Lumley AI, Devaux Y., Targeting regulatory RNAs at the heart of Parkinson's disease, Eur Heart J, 44, 23, pp. 2059-2060, (2023)
  • [8] Rosenthal LS, Yang J, Mao X., Dysregulated miRNAs mark Parkinson's disease progression, Nat Aging, 1, 3, pp. 241-242, (2021)
  • [9] Lewis A, Mehta S, Hanna LN, Et al., Low Serum Levels of MicroRNA-19 Are Associated with a Stricturing Crohn's Disease Phenotype, Inflamm Bowel Dis, 21, 8, pp. 1926-1934, (2015)
  • [10] Amjad N, Yang R, Li L, Et al., Decrease of miR-19b-3p in Brain Microvascular Endothelial Cells Attenuates Meningitic Escherichia coli-Induced Neuroinflammation via TNFAIP3-Mediated NF-kappaB Inhibition, Pathogens, 8, 4, (2019)